TR201917675A2 - A WOUND CARE PRODUCT - Google Patents

A WOUND CARE PRODUCT Download PDF

Info

Publication number
TR201917675A2
TR201917675A2 TR2019/17675A TR201917675A TR201917675A2 TR 201917675 A2 TR201917675 A2 TR 201917675A2 TR 2019/17675 A TR2019/17675 A TR 2019/17675A TR 201917675 A TR201917675 A TR 201917675A TR 201917675 A2 TR201917675 A2 TR 201917675A2
Authority
TR
Turkey
Prior art keywords
care product
wound care
boric acid
wound
healing
Prior art date
Application number
TR2019/17675A
Other languages
Turkish (tr)
Inventor
Kapukaya Rana
Murat Özayman Nuri̇
Original Assignee
Ulusal Bor Arastirma Enstituesue
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ulusal Bor Arastirma Enstituesue filed Critical Ulusal Bor Arastirma Enstituesue
Priority to TR2019/17675A priority Critical patent/TR201917675A2/en
Priority to PCT/TR2020/051083 priority patent/WO2021096469A1/en
Publication of TR201917675A2 publication Critical patent/TR201917675A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/21—Acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Bu buluş, antibakteriyel bileşenleri olarak nano borik asit partikülleri ve asidik ortamda daha verimli olan antibiyotikler taşıyan, tamamlayıcı etkileri için ek bileşenler içeren bir yara bakım ürünü ile ilgilidir. Buluşun amacı, antibakteriyel bileşen olarak, teknikte sıklıkla kullanılan ancak zararlı yan etkilere sahip olan gümüş nitrat partikülleri yerine daha biyouyumlu olan borik asit nano partiküllerinin kullanıldığı, etkili salınım süresinin uzatıldığı, böylece hücre ve akyuvar proliferasyonunun indüklenmesini arttıran, yara izi bırakmadan yara iyileştirilmesini sağlayan ve yara iyileştirme sürecini hızlandıran bir yara bakım ürünü geliştirilmesidir.The present invention relates to a wound care product that contains nano boric acid particles as its antibacterial ingredients and antibiotics that are more efficient in an acidic environment, with additional ingredients for their complementary effects. The aim of the invention is to use boric acid nanoparticles, which are more biocompatible, instead of silver nitrate particles, which are frequently used in the technique but have harmful side effects, as an antibacterial component, to extend the effective release time, thus increasing the induction of cell and white blood cell proliferation, providing wound healing without scarring, and wound healing. is the development of a wound care product that accelerates the healing process.

TR2019/17675A 2019-11-13 2019-11-13 A WOUND CARE PRODUCT TR201917675A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2019/17675A TR201917675A2 (en) 2019-11-13 2019-11-13 A WOUND CARE PRODUCT
PCT/TR2020/051083 WO2021096469A1 (en) 2019-11-13 2020-11-11 A wound care product

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2019/17675A TR201917675A2 (en) 2019-11-13 2019-11-13 A WOUND CARE PRODUCT

Publications (1)

Publication Number Publication Date
TR201917675A2 true TR201917675A2 (en) 2021-05-21

Family

ID=75912268

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/17675A TR201917675A2 (en) 2019-11-13 2019-11-13 A WOUND CARE PRODUCT

Country Status (2)

Country Link
TR (1) TR201917675A2 (en)
WO (1) WO2021096469A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003062443A2 (en) * 2001-11-08 2003-07-31 Antex Pharma, Inc. Novel substituted alkane compounds and uses thereof
US20110008402A1 (en) * 2006-10-13 2011-01-13 Kane Biotech Inc. Souluble b-n-acetylglucoseaminidase based antibiofilm compositions and uses thereof
CA2738245A1 (en) * 2008-09-26 2010-04-01 Nanobio Corporation Nanoemulsion therapeutic compositions and methods of using the same
BR112012003804B1 (en) * 2009-08-21 2019-02-19 Novan, Inc. Wound Dressing, Method to Form an Injury Dressing, and Wound Dressing Kit
WO2014165253A1 (en) * 2013-03-12 2014-10-09 Nbip, Llc Compositions and methods for preventing infection of a wound and for advancing the healing process

Also Published As

Publication number Publication date
WO2021096469A1 (en) 2021-05-20

Similar Documents

Publication Publication Date Title
CY1121663T1 (en) GEMCITAVINE-[PHENYL-(BENZYLOXY-L-ALANINYL)]-PHOSPHATE RP/SP MIXTURE
CY1124663T1 (en) N4-HYDROXYCYTIDINE ANTIBIOTIC DERIVATIVES
CY1122186T1 (en) CANCER TREATMENT METHODS
GT201300232A (en) MODULATION OF SIGNAL TRANSDUCER EXPRESSION AND TRANSCRIPTION ACTIVATOR 3 (STAT3)
SA517381996B1 (en) Composition for a wound dressing
CY1122305T1 (en) HYDROXAMIC ACID HYDROXAZOLE COMPOUNDS AS LPXC INHIBITORS
CA2919397C (en) Aryl ethers as hif-2.alpha. inhibitors for the treatment of cancer
MX2017016789A (en) Antibacterial compounds.
PH12016501512B1 (en) Treatment for resistant acne
BR112015026307A2 (en) bicyclic heterocycles as fgfr inhibitors
EA201692502A1 (en) MIEL TREATMENT
TR201905586T4 (en) FORMULATIONS CONTAINING AMORF DAPAGLIFLOZINE
TR201909626T4 (en) Composition containing ectoin or hydroxyectoin as promoting the healing of injured body tissue.
EA201691155A1 (en) COMBINATION INHIBITORS OF HISTONDEACETYLASE AND IMMUNOMODULATING MEDICINES
ZA201805792B (en) Taurine and aloe synergistic anti-irritant compositions and methods
BR112016003201A2 (en) selective grp94 inhibitors and uses thereof
TR201906865T4 (en) Surface treatment of particles and their use.
CY1123194T1 (en) NEW ANTIBACTERIAL COMPOUNDS
BR112017007817A2 (en) cancer treatment with immune boosters
BR112015026388A2 (en) wound healing methods and compositions
WO2017136731A8 (en) Rapaglutins, novel inhibitors of glut and use thereof
PH12020551994A1 (en) Tlr7 agonists
MX363604B (en) Composition comprising a combination of an acrylic polymer, a silicone copolymer and an amino acid or amino acid derivative.
MX355146B (en) Tooth varnish compositions and methods for their use.
BR112019005815A2 (en) methods of treating an individual with breast cancer, breast cancer treatment kit, and breast cancer therapy drug combination